title: In reply: response to Marioni.
authors.forename: David N
authors.initials: DN
authors.lastname: Church
authors.forename: Denis C
authors.initials: DC
authors.lastname: Talbot
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism*; D006258:Head and Neck Neoplasms / Q000378:metabolism*; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000037:antagonists & inhibitors*; D009369:Neoplasms / Q000188:drug therapy*; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D051034:Inhibitor of Apoptosis Proteins